142 related articles for article (PubMed ID: 19850993)
1. Clinical presentation and surgical management of invasive lobular carcinoma of the breast.
Dedes KJ; Fink D
Breast Dis; 2008-2009; 30():31-7. PubMed ID: 19850993
[TBL] [Abstract][Full Text] [Related]
2. Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis, surgical and medical treatment.
Biglia N; Mariani L; Sgro L; Mininanni P; Moggio G; Sismondi P
Endocr Relat Cancer; 2007 Sep; 14(3):549-67. PubMed ID: 17914088
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
4. Identifying patients at risk of compromised margins following breast conservation for lobular carcinoma.
Dillon MF; Hill AD; Fleming FJ; O'Doherty A; Quinn CM; McDermott EW; O'Higgins N
Am J Surg; 2006 Feb; 191(2):201-5. PubMed ID: 16442946
[TBL] [Abstract][Full Text] [Related]
5. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A
Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020
[TBL] [Abstract][Full Text] [Related]
6. [Breast-conserving treatment for early invasive lobular breast cancer: 15 years results].
Fodor J; Sulyok Z; Polgár C; Major T; Tóth J; Németh G
Magy Seb; 2001 Aug; 54(4):209-14. PubMed ID: 11550486
[TBL] [Abstract][Full Text] [Related]
7. Nonpalpable versus palpable invasive breast tumors treated with breast-conserving surgical management.
Tafra L; Essner R; Brenner RJ; Giuliano AE
Am Surg; 1996 May; 62(5):395-9. PubMed ID: 8615571
[TBL] [Abstract][Full Text] [Related]
8. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology.
Monti S; Galimberti V; Trifiro G; De Cicco C; Peradze N; Brenelli F; Fernandez-Rodriguez J; Rotmensz N; Latronico A; Berrettini A; Mauri M; Machado L; Luini A; Paganelli G
Ann Surg Oncol; 2007 Oct; 14(10):2928-31. PubMed ID: 17674108
[TBL] [Abstract][Full Text] [Related]
9. The feasibility of intraoperative diagnosis of sentinel lymph node metastases in breast cancer.
Leidenius MH; Krogerus LA; Toivonen TS; Von Smitten KJ
J Surg Oncol; 2003 Oct; 84(2):68-73. PubMed ID: 14502779
[TBL] [Abstract][Full Text] [Related]
10. Factors predicting non-sentinel lymph node involvement in sentinel node positive breast carcinoma.
Durak MG; Akansu B; Akin MM; Sevınç AI; Koçdor MA; Saydam S; Harmancioğlu O; Ellıdokuz H; Bekış R; Canda T
Turk Patoloji Derg; 2011; 27(3):189-95. PubMed ID: 21935867
[TBL] [Abstract][Full Text] [Related]
11. Axillary staging utilizing selective sentinel lymphadenectomy for patients with invasive breast carcinoma.
Dale PS; Williams JT
Am Surg; 1998 Jan; 64(1):28-31; discussion 32. PubMed ID: 9457034
[TBL] [Abstract][Full Text] [Related]
12. [Clinical usefulness and perspectives of sentinel node biopsy in the management of breast cancer].
Haid A; Koeberle-Wuehrer R; Offner F; Jasarevic Z; Fritzsche H; Zimmermann G
Chirurg; 2003 Jul; 74(7):657-64. PubMed ID: 12883794
[TBL] [Abstract][Full Text] [Related]
13. Clear margins for invasive lobular carcinoma: a surgical challenge.
Sakr RA; Poulet B; Kaufman GJ; Nos C; Clough KB
Eur J Surg Oncol; 2011 Apr; 37(4):350-6. PubMed ID: 21277728
[TBL] [Abstract][Full Text] [Related]
14. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S
J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
[TBL] [Abstract][Full Text] [Related]
15. Sentinel node biopsy in elderly breast cancer patients.
Gennari R; Rotmensz N; Perego E; dos Santos G; Veronesi U
Surg Oncol; 2004 Dec; 13(4):193-6. PubMed ID: 15615656
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections.
Tot T
Cancer; 2007 Dec; 110(11):2551-60. PubMed ID: 17932896
[TBL] [Abstract][Full Text] [Related]
17. Infiltrating lobular carcinoma--a comparison of diagnosis, management and outcome with infiltrating duct carcinoma.
Molland JG; Donnellan M; Janu NC; Carmalt HL; Kennedy CW; Gillett DJ
Breast; 2004 Oct; 13(5):389-96. PubMed ID: 15454194
[TBL] [Abstract][Full Text] [Related]
18. [Second operation more frequent following breast-conserving treatment for invasive lobular than for invasive non-lobular carcinoma].
de Zeeuw S; Wildenberg F; Strobbe L; Wobbes T
Ned Tijdschr Geneeskd; 2009; 153():A56. PubMed ID: 19900317
[TBL] [Abstract][Full Text] [Related]
19. Secondary operations are frequently required to complete the surgical phase of therapy in the era of breast conservation and sentinel lymph node biopsy.
Mullenix PS; Cuadrado DG; Steele SR; Martin MJ; See CS; Beitler AL; Carter PL
Am J Surg; 2004 May; 187(5):643-6. PubMed ID: 15135683
[TBL] [Abstract][Full Text] [Related]
20. Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? analysis of an institutional database over a 10-year period.
Fortunato L; Mascaro A; Poccia I; Andrich R; Amini M; Costarelli L; Cortese G; Farina M; Vitelli C
Ann Surg Oncol; 2012 Apr; 19(4):1107-14. PubMed ID: 21913022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]